Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Calcium Channel Blocker Global Market Report 2025
Request Sample Buy Now
Global Calcium Channel Blocker Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Calcium Channel Blocker Global Market Report 2025

By Drug Class (Dihydropyridine, Benzothiazepine, Phenylalkylamine, Other Drug Classes), By Disease Indications (Hypertension, Chest Pain, Arrhythmias), By Route Of Administration (Oral, Parenteral, Other Route Of Administration), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Calcium Channel Blocker Market Overview

• Calcium Channel Blocker market size has reached to $15.56 billion in 2024

• Expected to grow to $21.59 billion in 2029 at a compound annual growth rate (CAGR) of 7%

• Growth Driver: Rising Prevalence Of Cardiovascular Diseases Propels Growth In The Calcium Channel Blocker Market

• Market Trend: Innovative Advancements In The Calcium Channel Blocker Market

• North America was the largest region in 2024.

What Is Covered Under Calcium Channel Blocker Market?

Calcium channel blockers refer to a type of drug that prevents calcium from entering the muscle cells of the heart and blood vessels. Calcium channel blockers are used to treat a variety of disorders, including high blood pressure, angina, and irregular heartbeats.

The drug types involved in calcium channel blockers are dihydropyridine, benzothiazepine, phenylalkylamine, and others. Dihydropyridines refer to a class of drugs that block calcium channels in the heart and arterial blood vessel muscle cells, decreasing the number of calcium ions that can enter the cell. The disease indications involved are hypertension, chest pain and arrhythmias that are administrated by oral, parenteral, and other routes of administration and used by hospitals, homecare, specialty clinics, and other end users.

Calcium Channel Blocker Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

What Is The Calcium Channel Blocker Market Size 2025 And Growth Rate?

The calcium channel blocker market size has grown strongly in recent years. It will grow from $15.56 billion in 2024 to $16.46 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increased incidence of cardiovascular diseases, aging population, advancements in medical research, changing lifestyles, increased awareness.

What Is The Calcium Channel Blocker Market Growth Forecast?

The calcium channel blocker market size is expected to see strong growth in the next few years. It will grow to $21.59 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to rising global burden of cardiovascular diseases, personalized medicine trends, increased access to healthcare, expansion of indications, regulatory approvals and market expansions. Major trends in the forecast period include market growth, technological advancements, regulatory landscape, competitive analysis, patient preferences and awareness.

The forecast of 7.0% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. cardiology practices by driving up costs of calcium channel blockers sourced from China and Singapore, exacerbating hypertension management expenses and increasing cardiovascular treatment burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Calcium Channel Blocker Market Segmented?

1) By Drug Class: Dihydropyridine, Benzothiazepine, Phenylalkylamine, Other Drug Classes

2) By Disease Indications: Hypertension, Chest Pain, Arrhythmias

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Dihydropyridine: Amlodipine, Nifedipine, Felodipine, Nicardipine, Isradipine

2) By Benzodiazepine: Diazepam

3) By Phenylalkylamine: Verapamil

4) By Other Drug Classes: Bepridil, Lercanidipine, Cilnidipine

What Is Driving The Calcium Channel Blocker Market? Rising Prevalence Of Cardiovascular Diseases Propels Growth In The Calcium Channel Blocker Market

The increasing prevalence rate of cardiovascular diseases is expected to boost the growth of the calcium channel blocker market going forward. Cardiovascular disease refers to a type of condition that affects the heart or blood vessels. Calcium channel blockers (CCBs) are used to lower the risk of heart failure and stroke. Hence, the increasing prevalence rate of cardiovascular diseases will result in a rise in demand for the calcium channel blockers. For instance, in August 2022, according to a report published by the American College of Cardiology, a US-based non-profit medical association, In the United States, it is anticipated that all four cardiovascular risk factors will increase between 2025 and 2060. The largest percentage rise is expected in diabetes, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). The researchers also observed that the most substantial projected increases in cardiovascular disease rates were for stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), followed by ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million). Therefore, the increasing prevalence rate of cardiovascular diseases is driving the growth of the calcium channel blocker industry.

What Is Driving The Calcium Channel Blocker Market? The Impact Of Rising Healthcare Expenditure On The Calcium Channel Blocker Market

The increasing healthcare expenditure is expected to boost the growth of the calcium channel blocker market going forward. Healthcare expenditure refers to the total amount of resources, including financial resources, which are allocated and spent on healthcare services and related activities within a specific time frame, usually measured annually. Elevated healthcare spending fosters a favorable environment for the calcium channel blocker market, enhancing access, affordability, research and development, and overall patient care, thereby contributing to the establishment of a robust healthcare ecosystem for the effective management of cardiovascular conditions. For instance, in July 2024, according to the American Medical Association, a US-based Professional organization company, in 2022, health expenditures in the U.S. rose by 4.1%, totaling $4.5 trillion, which amounts to $13,493 per person. Therefore, the increasing healthcare expenditure is driving the growth of the calcium channel blocker industry.

Who Are The Major Players In The Global Calcium Channel Blocker Market?

Major companies operating in the calcium channel blocker market include Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bausch Health Companies Inc., Lupin Pharmaceuticals Inc., Cadila Healthcare Limited, Covis Pharma BV, Glenmark Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sofgen Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Knoll Healthcare Private Limited, Sanofi S.A., Clearsynth Labs Ltd., Searle LLC, Bayer AG, AstraZeneca plc, Wyeth-Ayerst Lederle Inc., GlaxoSmithKline Plc., AbbVie Inc., Silvergate Pharmaceuticals Inc., Exela Pharma Sciences LLC, Arbor Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd.

What Are The Key Trends Of The Global Calcium Channel Blocker Market? Innovative Advancements In The Calcium Channel Blocker Market

Product innovation is the key trend gaining popularity in the calcium channel blocker market. Major companies operating in the calcium channel blockers market are focusing on developing innovative products to sustain their market position. For instance, in June 2022, CMP Pharma, a US-based pharmaceutical manufacturing company, launched Norliqva, the first and only oral liquid solution of the besylate salt of amlodipine, a long-acting calcium channel blocker. The unique feature of Norliqva is that it is an amlodipine liquid solution used to treat hypertension in people 6 years of age and older. Norliqva prevents the difficulties and irregularities of crushing or synthesizing amlodipine tablets and guarantees uniform dosing and bioequivalence. Norliqva is meant for a subset of patients who require amlodipine but have swallowing issues or are unable to swallow.

What Are The Key Trends Of The Global Calcium Channel Blocker Market? Innovative Advancements In The Calcium Channel Blocker Market

Major companies operating in the calcium channel blocker market are developing innovative products such as tablets for pulmonary arterial hypertension to meet larger customer bases, more sales, and increase revenue. In the context of Pulmonary Arterial Hypertension (PAH), a tablet refers to an oral pharmaceutical formulation designed for the treatment of this specific medical condition. For instance, in May 2022, Zydus, an India-based pharmaceutical company, announced the US Food and Drug Administration (FDA) approval for Selexipag tablets. Selexipag is prescribed in adults to manage Pulmonary Arterial Hypertension (PAH), aiming to delay the progression of the disease and minimize the likelihood of hospitalization associated with PAH. This medication functions as a prostacyclin receptor agonist.

Need data on a specific region in this market?
Request Customisation

Calcium Channel Blocker Market Merger And Acquisition: LXO Group Acquires Nimotop To Strengthen Market Presence And Enhance Product Offerings

In November 2023, LXO Group, a France-based pharmaceutical company that focuses on non-generic prescription medicines, acquired Nimotop from Bayer for an undisclosed amount. Through this acquisition, LXO Group aims to expand its market presence, enhance its product offerings, and drive innovation in the industry. Bayer AG is a Germany-based pharmaceutical and life sciences company, developing calcium channel blockers (CCB).

Regional Analysis For The Global Calcium Channel Blocker Market

North America was the largest region in the calcium channel blocker market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Calcium Channel Blocker Market?

The calcium channel blocker market consists of sales of amlodipine, nicardipine, isradipine, diltiazem, and verapamil drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Calcium Channel Blocker Industry?

The calcium channel blocker market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the calcium channel blocker industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Calcium Channel Blocker Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $16.46 billion
Revenue Forecast In 2034 $21.59 billion
Growth Rate CAGR of 7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Class: Dihydropyridine, Benzothiazepine, Phenylalkylamine, Other Drug Classes
2) By Disease Indications: Hypertension, Chest Pain, Arrhythmias
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments: 1) By Dihydropyridine: Amlodipine, Nifedipine, Felodipine, Nicardipine, Isradipine
2) By Benzodiazepine: Diazepam
3) By Phenylalkylamine: Verapamil
4) By Other Drug Classes: Bepridil, Lercanidipine, Cilnidipine
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bausch Health Companies Inc., Lupin Pharmaceuticals Inc., Cadila Healthcare Limited, Covis Pharma BV, Glenmark Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sofgen Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Knoll Healthcare Private Limited, Sanofi S.A., Clearsynth Labs Ltd., Searle LLC, Bayer AG, AstraZeneca plc, Wyeth-Ayerst Lederle Inc., GlaxoSmithKline Plc., AbbVie Inc., Silvergate Pharmaceuticals Inc., Exela Pharma Sciences LLC, Arbor Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Calcium Channel Blocker Market Characteristics

3. Calcium Channel Blocker Market Trends And Strategies

4. Calcium Channel Blocker Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Calcium Channel Blocker Growth Analysis And Strategic Analysis Framework

5.1. Global Calcium Channel Blocker PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Calcium Channel Blocker Market Growth Rate Analysis

5.4. Global Calcium Channel Blocker Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Calcium Channel Blocker Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Calcium Channel Blocker Total Addressable Market (TAM)

6. Calcium Channel Blocker Market Segmentation

6.1. Global Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dihydropyridine

Benzothizepine

Phenylalkylamine

Other Drug Classes

6.2. Global Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hypertension

Chest Pain

Arrhythmias

6.3. Global Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Other Route Of Administration

6.4. Global Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End Users

6.5. Global Calcium Channel Blocker Market, Sub-Segmentation Of Dihydropyridine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Amlodipine

Nifedipine

Felodipine

Nicardipine

Isradipine

6.6. Global Calcium Channel Blocker Market, Sub-Segmentation Of Benzodiazepine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diazepam

6.7. Global Calcium Channel Blocker Market, Sub-Segmentation Of Phenylalkylamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Verapamil

6.8. Global Calcium Channel Blocker Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bepridil

Lercanidipine

Cilnidipine

7. Calcium Channel Blocker Market Regional And Country Analysis

7.1. Global Calcium Channel Blocker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Calcium Channel Blocker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Calcium Channel Blocker Market

8.1. Asia-Pacific Calcium Channel Blocker Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Calcium Channel Blocker Market

9.1. China Calcium Channel Blocker Market Overview

9.2. China Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Calcium Channel Blocker Market

10.1. India Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Calcium Channel Blocker Market

11.1. Japan Calcium Channel Blocker Market Overview

11.2. Japan Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Calcium Channel Blocker Market

12.1. Australia Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Calcium Channel Blocker Market

13.1. Indonesia Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Calcium Channel Blocker Market

14.1. South Korea Calcium Channel Blocker Market Overview

14.2. South Korea Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Calcium Channel Blocker Market

15.1. Western Europe Calcium Channel Blocker Market Overview

15.2. Western Europe Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Calcium Channel Blocker Market

16.1. UK Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Calcium Channel Blocker Market

17.1. Germany Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Calcium Channel Blocker Market

18.1. France Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Calcium Channel Blocker Market

19.1. Italy Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Calcium Channel Blocker Market

20.1. Spain Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Calcium Channel Blocker Market

21.1. Eastern Europe Calcium Channel Blocker Market Overview

21.2. Eastern Europe Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Calcium Channel Blocker Market

22.1. Russia Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Calcium Channel Blocker Market

23.1. North America Calcium Channel Blocker Market Overview

23.2. North America Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Calcium Channel Blocker Market

24.1. USA Calcium Channel Blocker Market Overview

24.2. USA Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Calcium Channel Blocker Market

25.1. Canada Calcium Channel Blocker Market Overview

25.2. Canada Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Calcium Channel Blocker Market

26.1. South America Calcium Channel Blocker Market Overview

26.2. South America Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Calcium Channel Blocker Market

27.1. Brazil Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Calcium Channel Blocker Market

28.1. Middle East Calcium Channel Blocker Market Overview

28.2. Middle East Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Calcium Channel Blocker Market

29.1. Africa Calcium Channel Blocker Market Overview

29.2. Africa Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Calcium Channel Blocker Market Competitive Landscape And Company Profiles

30.1. Calcium Channel Blocker Market Competitive Landscape

30.2. Calcium Channel Blocker Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Lupin Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Calcium Channel Blocker Market Other Major And Innovative Companies

31.1. Cadila Healthcare Limited

31.2. Covis Pharma BV

31.3. Glenmark Pharmaceuticals Inc.

31.4. Amneal Pharmaceuticals LLC

31.5. Sofgen Pharmaceuticals

31.6. Teva Pharmaceutical Industries Ltd.

31.7. Knoll Healthcare Private Limited

31.8. Sanofi S.A.

31.9. Clearsynth Labs Ltd.

31.10. Searle LLC

31.11. Bayer AG

31.12. AstraZeneca plc

31.13. Wyeth-Ayerst Lederle Inc.

31.14. GlaxoSmithKline Plc.

31.15. AbbVie Inc.

32. Global Calcium Channel Blocker Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Calcium Channel Blocker Market

34. Recent Developments In The Calcium Channel Blocker Market

35. Calcium Channel Blocker Market High Potential Countries, Segments and Strategies

35.1 Calcium Channel Blocker Market In 2029 - Countries Offering Most New Opportunities

35.2 Calcium Channel Blocker Market In 2029 - Segments Offering Most New Opportunities

35.3 Calcium Channel Blocker Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Calcium Channel Blocker Market, Sub-Segmentation Of Dihydropyridine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Calcium Channel Blocker Market, Sub-Segmentation Of Benzodiazepine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Calcium Channel Blocker Market, Sub-Segmentation Of Phenylalkylamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Calcium Channel Blocker Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Calcium Channel Blocker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Calcium Channel Blocker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: GlaxoSmithKline plc Financial Performance
  • Table 81: Novartis AG Financial Performance
  • Table 82: Bausch Health Companies Inc. Financial Performance
  • Table 83: Lupin Pharmaceuticals Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Calcium Channel Blocker Market, Sub-Segmentation Of Dihydropyridine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Calcium Channel Blocker Market, Sub-Segmentation Of Benzodiazepine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Calcium Channel Blocker Market, Sub-Segmentation Of Phenylalkylamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Calcium Channel Blocker Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Calcium Channel Blocker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Calcium Channel Blocker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: GlaxoSmithKline plc Financial Performance
  • Figure 81: Novartis AG Financial Performance
  • Figure 82: Bausch Health Companies Inc. Financial Performance
  • Figure 83: Lupin Pharmaceuticals Inc. Financial Performance

Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Read More About Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Read More About Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Read More About Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Read More About Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Pressure Pumping Global Market Report 2025 – By Pump Type (Dynamic, Positive Displacement), By Pressure (Low, Medium, High), By Application (Oil And Gas, Mining, Chemical, Municipalities, Marine, Automotive, Food And Bev...

View Report

Pipettes And Accessories Global Market Report 2025 – By Type (Manual Pipettes, Electronic Pipettes, Accessories), By Channel Type (Single Channel, Multi-Channel), By Application (Hospitals, Academic And Research Institut...

View Report

Ultrasound Transducer Global Market Report 2025 – By Product (Linear, Convex, Phased array, Endocavitary, Continuous wave Doppler, Other Products), By Application (Cardiovascular, General Imaging, Musculoskeletal, Obstet...

View Report

Pediatric Medical Devices Global Market Report 2025 – By Product (Cardiology Devices, In Vitro Diagnostic (IVD) Devices, Diagnostic Imaging Devices, Anesthesia And Respiratory Care Devices, Neonatal Intensive Care Unit (...

View Report

Pet Cloning Global Market Report 2025 – By Product Or Type (Deceased Pet Cloning, Alive Pet Cloning), By Technique (Somatic Cell Nuclear Transfer, Gene Editing, Other Techniques), By Application (Dogs, Cats, Horses, Bird...

View Report

Osteoporosis Treatment Global Market Report 2025 – By Drug Type (Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog, Rank Liga...

View Report

Plastic Additives Global Market Report 2025 – By Type (Plasticizers, Flame Retardants, Impact Modifiers, Lubricants, Antioxidants, Antimicrobials, Ultra-Violet (UV) Stabilizers, Other Types), By Plastic Type (Polystyrene...

View Report

Frequently Asked Questions

Calcium channel blockers refer to a type of drug that prevents calcium from entering the muscle cells of the heart and blood vessels. Calcium channel blockers are used to treat a variety of disorders, including high blood pressure, angina, and irregular heartbeats. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Cardiovascular Diseases Propels Growth In The Calcium Channel Blocker Market. For further insights on this market, request a sample here

The calcium channel blocker market size has grown strongly in recent years. It will grow from $15.56 billion in 2024 to $16.46 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increased incidence of cardiovascular diseases, aging population, advancements in medical research, changing lifestyles, increased awareness. The calcium channel blocker market size is expected to see strong growth in the next few years. It will grow to " $21.59 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to rising global burden of cardiovascular diseases, personalized medicine trends, increased access to healthcare, expansion of indications, regulatory approvals and market expansions. Major trends in the forecast period include market growth, technological advancements, regulatory landscape, competitive analysis, patient preferences and awareness. For further insights on this market, request a sample here

The calcium channel blocker market covered in this report is segmented –
1) By Drug Class: Dihydropyridine, Benzothiazepine, Phenylalkylamine, Other Drug Classes
2) By Disease Indications: Hypertension, Chest Pain, Arrhythmias
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments:
1) By Dihydropyridine: Amlodipine, Nifedipine, Felodipine, Nicardipine, Isradipine
2) By Benzodiazepine: Diazepam
3) By Phenylalkylamine: Verapamil
4) By Other Drug Classes: Bepridil, Lercanidipine, Cilnidipine For further insights on this market, request a sample here

North America was the largest region in the calcium channel blocker market in 2024. The regions covered in the calcium channel blocker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the calcium channel blocker market include Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bausch Health Companies Inc., Lupin Pharmaceuticals Inc., Cadila Healthcare Limited, Covis Pharma BV, Glenmark Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sofgen Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Knoll Healthcare Private Limited, Sanofi S.A., Clearsynth Labs Ltd., Searle LLC, Bayer AG, AstraZeneca plc, Wyeth-Ayerst Lederle Inc., GlaxoSmithKline Plc., AbbVie Inc., Silvergate Pharmaceuticals Inc., Exela Pharma Sciences LLC, Arbor Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Advancements In The Calcium Channel Blocker Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Calcium Channel Blocker Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon